Navigation Links
IDEV gibt Ergebnisse von Studie zur Revaskularisation mit Supera an echten Patienten (RESTORE) bekannt - Studie demonstriert positive klinische Ergebnisse bei schwerkranken Patienten mit langen Läsionen
Date:2/1/2013

WEBSTER, Texas, 1. Februar 2013 /PRNewswire/ -- IDEV Technologies, Inc. gab heute Ergebnisse einer neuen Studie bekannt, die durch Ärzte aus Tucson, Arizona durchgeführt wurde. Die Ergebnisse wurden vergangene Woche beim LINC in Leipzig (Deutschland) präsentiert.  Die Daten stimmen mit zuvor veröffentlichten Ergebnissen für das Supera® Stent überein, die in anderen Studien erreicht wurden, sich jedoch auf Patienten mit peripheren Erkrankungen in einem fortgeschritteneren Stadium bezogen.

147 Patienten aus Tucson wurden bei der Auswertung berücksichtigt.  Untersucht wurden lange Läsionen, wobei die durchschnittliche Läsionenlänge der Erkrankungen der oberflächlichen Arteria femoralis und der Arteria poplitea 18,4 cm betrug. Diese wurde durch eine durchschnittliche Stentlänge von 19,7 cm behandelt.  Die Studie umfasste Patienten mit Typ-C- und Typ-D-Läsionen der TASC-II-Klassifikation (28 % bzw. 33 %).  Zusätzlich litten 35 % der Patienten unter Gewebeverlust und wurden mit Rutherford Becker als 5 und 6 klassifiziert; 53 % aller Patienten litten unter chronischen Komplettverschlüssen.  Die übergreifende primäre Durchgängigkeitsquote wurde durch den Duplex-Ultraschall gemessen und betrug bei der Nachsorgeuntersuchung nach einem Jahr 88 %.  In einer Untergruppenanalyse von 47 Patienten, die Nachsorge-Röntgenuntersuchungen erhielten, wurden keine Frakturen festgestellt.

„Unsere Studie umfasste Patienten, die schwer erkrankt waren", kommentiert John Pacanowski , M. D., Chief of Vascular Surgery, Tucson Medical Center. Basierend auf dem umfassenden Datenvolumen für Supera sowie den Ergebnissen unserer Studie, sind wir davon überzeugt, dass Supera
'/>"/>

SOURCE IDEV Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
2. GLP Preclinical Studies Demonstrate nContact Ablation Lesions Are Complete and Transmural
3. Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
4. Laut einer Studie setzen sich die großen Pharmaunternehmen mehr für den Zugang zu Medizin in Entwicklungsländern ein als noch vor zwei Jahren
5. The Lancet Publication Of LAPLACE-TIMI 57 And MENDEL Studies Showed AMG 145 Significantly Reduced LDL Cholesterol
6. Novel Apolipoprotein A-I Therapy, CSL112, May Represent New Option for Reducing Recurrent Heart Attack Risk, Early CSL Studies Show
7. Amgen To Present Data From Four Phase 2 Studies At Upcoming American Heart Association Scientific Sessions 2012
8. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
9. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
10. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
11. PartTecs Newly Licensed Neutron Detector Will Advance Human Disease Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Kewaunee Scientific Corporation (Nasdaq: KEQU ... quarterly cash dividend by 9% to twelve cents per ... with the dividend payable on September 22, 2014 to ... September 8, 2014. About Kewaunee Scientific ... Corporation is a recognized global leader in the design, ...
(Date:8/27/2014)... N.J. and NINGBO, China ... and the Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today ... the development of generic pharmaceuticals, primarily targeting ... of the agreement, Amerigen and Menovo will jointly develop ... United States . Menovo will be responsible for ...
(Date:8/27/2014)... 27, 2014 Ambit Biosciences (Nasdaq: AMBI ), ... targeting unmet needs in oncology, autoimmune and inflammatory disease, today ... Conference to be held at The New York Palace Hotel ... 3-4, 2014. Alan Fuhrman , Ambit,s CFO, ... drug candidate, quizartinib, at 1:10 p.m. ET on Wednesday, September ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Ambit Announces Participation At Baird 2014 Health Care Conference 2
... Inc. (NYSE Amex: INO ), which is advancing ... that Dr. J. Joseph Kim, President and CEO, will present ... Healthcare Conference taking place December 13-14 at the Waldorf-Astoria in ... 13 10:50 am ET A live and archived ...
... Dec. 11, 2011   TetraLogic Pharmaceuticals , a biopharmaceutical ... treat cancer, today announced the oral presentation of new ... the 53rd ASH Annual Meeting and Exposition in San ... M. D. Anderson Cancer Center, demonstrated that TL32711 induces ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference 2Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference 3TetraLogic Pharmaceuticals Announces Oral Presentation on Smac Mimetic TL32711 at American Society of Hematology (ASH) Annual Meeting 2
(Date:8/27/2014)... DiaSorin has announced that their new webinar , ... guest speaker Dr. Gregory A. Plotnikoff, a physician and ... Integrative Medicine. Dr. Plotnikoff serves as an integrative medicine ... Healing and as Senior Consultant, Center for Health Care ... as a co-editor of the new journal Global Advances ...
(Date:8/27/2014)... August 28, 2014 National Resident ... in the Association for Medical Education in Europe (AMEE) ... Milan, Italy August 30 – September 3, 2014. ... the international medical education community, share the benefits of ... strengthen resident physician placement in countries throughout the world. ...
(Date:8/27/2014)... Delta, a reliable supplier of high quality ... D7R Dozers to its used bulldozer collection. ... that all these items are offered with deep discounts. ... Delta’s market share in the coming September. , ... offer; he has much confidence in the discounted Used ...
(Date:8/27/2014)... Philadelphia, PA. Inc. magazine ranked Holganix as ... an exclusive ranking of the nation’s fastest-growing privately held ... the most important segment of the economy - America’s ... as members of the Inc. 500 list include Dell, ... of world’s greatest companies have had their start on ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Reviewing the ... will now be easier for the public when using ... that are promoted in all 50 states in the ... , The different insurers that are generating the rates ... possible for adults to use the programmed system without ...
Breaking Medicine News(10 mins):Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 3Health News:National Resident Matching Program International (NRMPI) to Exhibit at the 2014 AMEE Conference 2Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Inc Magazine Unveils 33rd Annual List of America's Fastest-Growing Private Companies - the Inc. 500 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2
... Pacific Dental Services (PDS(TM)) provided dentistry to the Community of ... Los Angeles , Over 250 employees, affiliated dentists and family members helped those ... in need , World Impact, Inc.(C) was a ... ...
... obesity epidemic in explaining the troubling trend , , TUESDAY, ... pronounced reduction in risk factors for heart disease is ... that the trend has flattened, starting at the beginning ... date back a fair amount of time, but now ...
... 11 The number of heart attack patients,admitted to ... smoking ban were implemented, according to a Henry Ford,Hospital ... hospital admissions from,1999-2006 in Michigan for what is known ... a smoking ban could lead to 3,340 fewer,admissions annually., ...
... Anthem Blue Cross and,Blue Shield in Maine is ranked ... according to the current (Nov. 17) issue of U.S. ... recognition as,one of the nation,s best health plans is ... member satisfaction and NCQA,accreditation., "We work hard to ...
... in Thermotherapy, ALAMEDA, Calif. and PITTSBURGH, Nov. ... today the introduction of ReBound, a new and,innovative ... and joint contractures using radio frequency (RF) diathermy. ... treatment systems,to the physical therapy and athletic training ...
... and prevention, new report finds , , TUESDAY, Nov. 11 ... of educational materials, and meager data collection are hindering ... driving in the United States and aggressively tackle the ... Foundation (NSF) released its findings Tuesday as part of ...
Cached Medicine News:Health News:Watts Powerhouse Church Receives a Facelift Through the Volunteers of Pacific Dental Services(R) 2Health News:Watts Powerhouse Church Receives a Facelift Through the Volunteers of Pacific Dental Services(R) 3Health News:After Decades, Decreases in Heart Risk Factors Level Off 2Health News:Study: Smoking Ban Would Help Reduce Heart Attack Admissions 2Health News:Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance America's Best Health Plans List 2Health News:Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance America's Best Health Plans List 3Health News:Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance America's Best Health Plans List 4Health News:Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance America's Best Health Plans List 5Health News:Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance America's Best Health Plans List 6Health News:Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance America's Best Health Plans List 7Health News:Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance America's Best Health Plans List 8Health News:Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance America's Best Health Plans List 9Health News:Game Ready(TM) and ReGear Life Sciences(TM) Bring Innovative New Heat Therapy to Market 2Health News:Game Ready(TM) and ReGear Life Sciences(TM) Bring Innovative New Heat Therapy to Market 3Health News:States Asleep at the Wheel in Fighting Drowsy Driving 2
For the quantitative determination of aspartate aminotransferase (AST) in human serum. The reagents are used in routine examination and monitoring of therapy and relapses....
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 440 U/L at 30C. Liquid buffer and dry powder r...
The Midas II Stainer is an automated slide stainer designed for use in hematology and microbiology laboratories....
... 44 is an "assembly-line worker" for routine ... cytology laboratories. It automatically stains big quantities ... increased large number of reagent stations in ... a high throughput. Up to 12 baskets ...
Medicine Products: